sb.scorecardresearch
Advertisement

Published 18:25 IST, September 4th 2020

Russian COVID-19 vaccine safe, induces antibody response in small trials: Study

Results from early-phase non-randomised vaccine trials in a total of 76 people show that two formulations of the vaccine have a good safety profile detected over 42 days, and induce antibody responses in all participants within 21 days

Follow: Google News Icon
  • share
null | Image: self
Advertisement

Loading...

18:25 IST, September 4th 2020